211 related articles for article (PubMed ID: 32442543)
1. Acetylcholinesterase inhibition resulting from exposure to inhaled OP can be prevented by pretreatment with BChE in both macaques and minipigs.
Rosenberg Y; Saxena A
Neuropharmacology; 2020 Sep; 174():108150. PubMed ID: 32442543
[TBL] [Abstract][Full Text] [Related]
2. Pulmonary delivery of an aerosolized recombinant human butyrylcholinesterase pretreatment protects against aerosolized paraoxon in macaques.
Rosenberg YJ; Laube B; Mao L; Jiang X; Hernandez-Abanto S; Lee KD; Adams R
Chem Biol Interact; 2013 Mar; 203(1):167-71. PubMed ID: 23178380
[TBL] [Abstract][Full Text] [Related]
3. Aerosolized recombinant human butyrylcholinesterase delivered by a nebulizer provides long term protection against inhaled paraoxon in macaques.
Rosenberg Y; Fink J; MacLoughlin R; Ooms-Konecny T; Sullivan D; Gerk W; Mao L; Jiang X; Lees J; Urban L; Rajendran N
Chem Biol Interact; 2019 Aug; 309():108712. PubMed ID: 31201777
[TBL] [Abstract][Full Text] [Related]
4. Creation of a protective pulmonary bioshield against inhaled organophosphates using an aerosolized bioscavenger.
Rosenberg YJ; Fink JB
Ann N Y Acad Sci; 2016 Jun; 1374(1):151-8. PubMed ID: 27371808
[TBL] [Abstract][Full Text] [Related]
5. Post-exposure treatment with the oxime RS194B rapidly reactivates and reverses advanced symptoms of lethal inhaled paraoxon in macaques.
Rosenberg YJ; Wang J; Ooms T; Rajendran N; Mao L; Jiang X; Lees J; Urban L; Momper JD; Sepulveda Y; Shyong YJ; Taylor P
Toxicol Lett; 2018 Sep; 293():229-234. PubMed ID: 29129799
[TBL] [Abstract][Full Text] [Related]
6. Estimation of the upper limit of human butyrylcholinesterase dose required for protection against organophosphates toxicity: a mathematically based toxicokinetic model.
Ashani Y; Pistinner S
Toxicol Sci; 2004 Feb; 77(2):358-67. PubMed ID: 14600276
[TBL] [Abstract][Full Text] [Related]
7. Human butyrylcholinesterase as a general prophylactic antidote for nerve agent toxicity. In vitro and in vivo quantitative characterization.
Raveh L; Grunwald J; Marcus D; Papier Y; Cohen E; Ashani Y
Biochem Pharmacol; 1993 Jun; 45(12):2465-74. PubMed ID: 8328984
[TBL] [Abstract][Full Text] [Related]
8. Post-exposure treatment with the oxime RS194B rapidly reverses early and advanced symptoms in macaques exposed to sarin vapor.
Rosenberg YJ; Mao L; Jiang X; Lees J; Zhang L; Radic Z; Taylor P
Chem Biol Interact; 2017 Aug; 274():50-57. PubMed ID: 28693885
[TBL] [Abstract][Full Text] [Related]
9. Protection against paraoxon toxicity by an intravenous pretreatment with polyethylene-glycol-conjugated recombinant butyrylcholinesterase in macaques.
Rosenberg YJ; Gearhart J; Mao L; Jiang X; Hernandez-Abanto S
Chem Biol Interact; 2014 Mar; 210():20-5. PubMed ID: 24384224
[TBL] [Abstract][Full Text] [Related]
10. Reactivation of organophosphate-inhibited serum butyrylcholinesterase by novel substituted phenoxyalkyl pyridinium oximes and traditional oximes.
Nichols RH; Chambers JE
Toxicology; 2021 Mar; 452():152719. PubMed ID: 33592259
[TBL] [Abstract][Full Text] [Related]
11. A single post-exposure oxime RS194B treatment rapidly reactivates acetylcholinesterase and reverses acute symptoms in macaques exposed to diethylphosphorothioate parathion and chlorpyrifos insecticides.
Rosenberg YJ; Garcia K; Diener J; Sullivan D; Donahue S; Mao L; Lees J; Jiang X; Urban LA; Momper JD; Ho KY; Taylor P
J Neurochem; 2024 Apr; 168(4):370-380. PubMed ID: 36786545
[TBL] [Abstract][Full Text] [Related]
12. Bioscavengers for the protection of humans against organophosphate toxicity.
Doctor BP; Saxena A
Chem Biol Interact; 2005 Dec; 157-158():167-71. PubMed ID: 16293236
[TBL] [Abstract][Full Text] [Related]
13. Characterization of Cholinesterases From Multiple Large Animal Species for Medical Countermeasure Development Against Chemical Warfare Nerve Agents.
McGarry KG; Schill KE; Winters TP; Lemmon EE; Sabourin CL; Harvilchuck JA; Moyer RA
Toxicol Sci; 2020 Mar; 174(1):124-132. PubMed ID: 31879781
[TBL] [Abstract][Full Text] [Related]
14. Prophylaxis with human serum butyrylcholinesterase protects Göttingen minipigs exposed to a lethal high-dose of sarin vapor.
Saxena A; Hastings NB; Sun W; Dabisch PA; Hulet SW; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2015 Aug; 238():161-9. PubMed ID: 26145887
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment with human serum butyrylcholinesterase alone prevents cardiac abnormalities, seizures, and death in Göttingen minipigs exposed to sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Biochem Pharmacol; 2011 Dec; 82(12):1984-93. PubMed ID: 21968035
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of human serum butyrylcholinesterase against sarin vapor.
Saxena A; Sun W; Dabisch PA; Hulet SW; Hastings NB; Jakubowski EM; Mioduszewski RJ; Doctor BP
Chem Biol Interact; 2008 Sep; 175(1-3):267-72. PubMed ID: 18597747
[TBL] [Abstract][Full Text] [Related]
17. Prophylaxis against soman inhalation toxicity in guinea pigs by pretreatment alone with human serum butyrylcholinesterase.
Allon N; Raveh L; Gilat E; Cohen E; Grunwald J; Ashani Y
Toxicol Sci; 1998 Jun; 43(2):121-8. PubMed ID: 9710953
[TBL] [Abstract][Full Text] [Related]
18. Comparison of polyethylene glycol-conjugated recombinant human acetylcholinesterase and serum human butyrylcholinesterase as bioscavengers of organophosphate compounds.
Cohen O; Kronman C; Raveh L; Mazor O; Ordentlich A; Shafferman A
Mol Pharmacol; 2006 Sep; 70(3):1121-31. PubMed ID: 16801396
[TBL] [Abstract][Full Text] [Related]
19. Naturally Occurring Genetic Variants of Human Acetylcholinesterase and Butyrylcholinesterase and Their Potential Impact on the Risk of Toxicity from Cholinesterase Inhibitors.
Lockridge O; Norgren RB; Johnson RC; Blake TA
Chem Res Toxicol; 2016 Sep; 29(9):1381-92. PubMed ID: 27551784
[TBL] [Abstract][Full Text] [Related]
20. Inhibition, reactivation and aging kinetics of highly toxic organophosphorus compounds: pig versus minipig acetylcholinesterase.
Worek F; Aurbek N; Wetherell J; Pearce P; Mann T; Thiermann H
Toxicology; 2008 Feb; 244(1):35-41. PubMed ID: 18054823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
